Several studies have used γ-glutamyl-p-nitroanilide (GPNA) to examine involvement of ASCT2 in cancer cell growth (e.g., Hassanein et al., 2013; Ren et al., 2015; Wang et al., 2015); however, the glutamine analog blocks a variety of glutamine transporters such as SNAT1, SNAT2 (Broer et al., 2016), and LAT1 (Chiu et al., 2017). This evidence concerns the gene SLC1A5 and cancer.